Trial Profile

A Phase II study exploring leronlimab's effects on inflammation

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 18 Sep 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

09 Sep 2024 According to a CytoDyn media release, the Company will continue to provide updates on this trial in the coming weeks, and expect to start screening patients in December 2024.
23 Aug 2024 According to a CytoDyn media release, company announced that it has engaged Syneos Health as the contract research organization for this upcoming Phase II study exploring leronlimab and its effects on chronic inflammation.
23 May 2024 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com